Relation of blood pressure to cognitive function in the elderly.

Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04

Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13

Association of higher diastolic blood pressure levels with cognitive impairment. Neurology (2009) 1.43

Influence of social support on cognitive function in the elderly. BMC Health Serv Res (2003) 1.23

Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan. BMC Nephrol (2012) 0.88

Hypertension and incident dementia in community-dwelling elderly Yoruba Nigerians. Acta Neurol Scand (2011) 0.83

Hypertension, cognitive decline, and dementia: an epidemiological perspective. Dialogues Clin Neurosci (2007) 0.81

Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden. BMC Cardiovasc Disord (2016) 0.78

Relationships between 24-Hour Blood Pressures, Subcortical Ischemic Lesions, and Cognitive Impairment. J Clin Neurol (2009) 0.78

Detection of mild cognitive impairment in people older than 65 years of age and its relationship to cardiovascular risk factors (DECRIVAM). BMC Public Health (2011) 0.78

Relation of Blood Pressure to Cognitive Impairment and Dementia. Curr Hypertens Rev (2007) 0.77

Cognitive impairment and nocturnal blood pressure fall in treated elderly hypertensives. Environ Health Prev Med (2003) 0.75

Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health (1993) 11.92

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA (1989) 8.36

Uncertainty in predictions of the climate response to rising levels of greenhouse gases. Nature (2005) 7.46

An improved and simplified method of detecting the acetylator phenotype. J Med Genet (1969) 6.40

Relation between malpractice claims and adverse events due to negligence. Results of the Harvard Medical Practice Study III. N Engl J Med (1991) 6.13

Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet (1980) 5.68

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord (2001) 5.09

Hospital characteristics associated with adverse events and substandard care. JAMA (1991) 4.77

Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75

Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci (1991) 4.53

Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J (1969) 4.21

Latent Semantic Indexing of medical diagnoses using UMLS semantic structures. Proc Annu Symp Comput Appl Med Care (1991) 4.09

Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol (1993) 3.74

Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61

Nomenclature for N-acetyltransferases. Pharmacogenetics (1995) 3.59

Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology (2003) 3.59

Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med (1996) 3.48

Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano) (1993) 3.47

Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40

Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br (1982) 3.39

Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology (2003) 3.35

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A (2002) 3.16

Inhibition by acetylene of conventional hydrogenase in nitrogen-fixing bacteria. Nature (1976) 3.11

Age-specific incidence of Alzheimer's disease in a community population. JAMA (1995) 3.09

Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun (2005) 3.06

Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med (1992) 2.92

Cognitive activity and incident AD in a population-based sample of older persons. Neurology (2002) 2.77

Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry (2004) 2.67

A prospective study of incident comprehensive medical home care use among the elderly. Am J Public Health (1988) 2.67

Social resources and cognitive decline in a population of older African Americans and whites. Neurology (2004) 2.66

Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology (2003) 2.60

Change in body mass index and risk of incident Alzheimer disease. Neurology (2005) 2.48

Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. J Consult Clin Psychol (1992) 2.43

Cognitive decline in incident Alzheimer disease in a community population. Neurology (2010) 2.41

Relationship between malpractice claims and cesarean delivery. JAMA (1993) 2.32

Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology (2003) 2.32

Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci (1999) 2.31

Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26

Chiral bis(oxazoline) copper(II) complexes: versatile catalysts for enantioselective cycloaddition, Aldol, Michael, and carbonyl ene reactions. Acc Chem Res (2000) 2.22

Age of Neoproterozoic bilatarian body and trace fossils, White Sea, Russia: implications for metazoan evolution. Science (2000) 2.21

Terminal decline in cognitive function. Neurology (2003) 2.18

Vacuum pack technique of temporary abdominal closure: a 7-year experience with 112 patients. J Trauma (2000) 2.13

Intracisternal A-particle genes in Mus musculus: a conserved family of retrovirus-like elements. Mol Cell Biol (1981) 2.07

Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol (1997) 2.07

Cognitive activity and cognitive decline in a biracial community population. Neurology (2003) 2.06

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology (2008) 1.97

Level of education and change in cognitive function in a community population of older persons. Ann Epidemiol (1993) 1.96

Epidemiology of disability in the oldest old: methodologic issues and preliminary findings. Milbank Mem Fund Q Health Soc (1985) 1.94

Cadaveric study of movement of an unstable atlanto-axial (C1/C2) cervical segment during laryngoscopy and intubation using the Airtraq(®) , Macintosh and McCoy laryngoscopes. Anaesthesia (2014) 1.93

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics (1997) 1.92

The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet (1983) 1.92

Trypanosoma brucei: Miniature anion-exchange centrifugation technique for detection of low parasitaemias: Adaptation for field use. Trans R Soc Trop Med Hyg (1979) 1.92

Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J Mol Biol (2006) 1.92

Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol (1993) 1.91

Temporal course of depressive symptoms during the development of Alzheimer disease. Neurology (2010) 1.87

Analysis of change in self-reported physical function among older persons in four population studies. Am J Epidemiol (1996) 1.86

The actylation of sulamethazine and sulfamethoxypyridazine by human subjects. Clin Pharmacol Ther (1968) 1.85

Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 1.84

Cognitive decline after hospitalization in a community population of older persons. Neurology (2012) 1.83

Empirical, automated vocabulary discovery using large text corpora and advanced natural language processing tools. Proc AMIA Annu Fall Symp (1996) 1.81

Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng Des Sel (2010) 1.80

Social networks and disability transitions across eight intervals of yearly data in the New Haven EPESE. J Gerontol B Psychol Sci Soc Sci (1999) 1.79

Reversible hypothyroidism in Addison's disease. Lancet (1972) 1.78

Educational attainment and cognitive decline in old age. Neurology (2009) 1.78

Impact of interruptions and distractions on dispensing errors in an ambulatory care pharmacy. Am J Health Syst Pharm (1999) 1.77

Development of vaccines for prevention of botulism. Biochimie (2000) 1.73

The polymorphic acetylation of sulphapyridine in man. J Med Genet (1972) 1.72

A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology (2003) 1.71

Oral aspirin in postoperative pain: a quantitative systematic review. Pain (1999) 1.71

Risk factors for delirium in hospitalized elderly. JAMA (1992) 1.70

Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol (2001) 1.70

Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. Ann Oncol (2011) 1.70

Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects. Gut (1972) 1.70

Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology (2005) 1.70

Genetic control of nortriptyline kinetics in man: a study of relatives of propositi with high plasma concentrations. J Med Genet (1971) 1.66

Synthesis of antibacterial p-quinols from marine sponges. Synthetic applications of "masked" quinones. J Org Chem (1977) 1.65

Evaluation of spontaneous reports of adverse reactions to drugs. Br Med J (1972) 1.64

Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med (2001) 1.63

Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A. J Mol Biol (2005) 1.62

Changes in lung function following the surgical treatment of bullous emphysema. Q J Med (1970) 1.61

Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med (1990) 1.61

Traditional criteria as predictors of minority student success in medical school. J Med Educ (1975) 1.61

Genetic polymorphism and interethnic variability of plasma paroxonase activity. J Med Genet (1976) 1.61

Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol (2000) 1.60

Epidemiology of injury in people with Alzheimer's disease. J Am Geriatr Soc (1995) 1.58

Genetic control of phenylbutazone metabolism in man. Br Med J (1970) 1.58

Associations of vegetable and fruit consumption with age-related cognitive change. Neurology (2006) 1.57

The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry (2002) 1.57

Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med (1982) 1.56

Cognitive activity and the cognitive morbidity of Alzheimer disease. Neurology (2010) 1.56

The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke (2005) 1.55

Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology (2004) 1.53